Prophylaxis of epidemic infantile pneumocystosis with a 20:1 sulfadoxine+pyrimethamine combination.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to C Post.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The absorption and distribution of bupivacaine in several tissues was studied after interpleural injection of 14C-labelled bupivacaine through a small needle interpleurally on the right side in male rats. 14C-labelled bupivacaine 10 microCi/mmol was injected at a dose of 2.5 mg/kg. The animals, a total of 42, six at each testing time, were sacrificed at 5, 10, 20, 30, 60, 120 and 180 minutes after the interpleural injection. Bupivacaine concentration was then determined on the basis of the amount of radioactivity in tissues taken from 23 different locations. The highest concentration of bupivacaine, about 40 pmol/micrograms tissue, was found in the right lung in the middle and inferior lobes. In the inferior and dorsal aspects of the right thoracic wall, the concentrations were in the same range. In the more peripheral organs, such as the musculature in the legs, the concentration was as low as less than 5 pmol/micrograms. In the central nervous system, the concentration was less than 10 pmol/micrograms. Our conclusion is that interpleurally administered bupivacaine remains in the area of injection for a considerable time.
In the present immunohistochemical study the occurrence and distribution of CCK-immunoreactive neurons were analyzed in the brain, spinal cord and sensory ganglia using sequence specific antisera. Thus, antibodies directed towards the C-terminal portion of CCK-33, to the N-terminal portion of CCK-8 and to the mid portion of CCK-33 as well as monoclonal antibodies were used. For comparison antisera raised against calcitonin gene-related peptide (CGRP), tyrosine hydroxylase (TH) and 5-hydroxytryptamine (5-HT) were used. Untreated, colchicine treated, 6-hydroxydopamine (6-OH-DA) treated and ibotenic acid treated rats were analyzed. The results indicate that most CCK systems in the rat central nervous system contain genuine CCK. These include, for example, the hippocampal formation, the hypothalamus, several subcortical forebrain areas, the ventral mesencephalon, nucleus tractus solitarii, some neurons in the ventral medulla oblongata as well as local and possibly descending neurons in the spinal cord. An exception was primary sensory neurons in which CCK-like immunoreactivity (LI) could only be demonstrated with C-terminally directed antisera and probably represents cross-reactivity with CGRP or a similar peptide. The central branches of such primary afferents were found both in the dorsal vagal complex, in the spinal trigeminal nucleus and in the dorsal horn of the spinal cord. Special attention was focused on CCK-LI in mesencephalic dopamine neurons and in their projection areas including nucleus accumbens, tuberculum olfactorium and particularly the caudate nucleus. In the latter structure CCK-LI exhibited a heterogenous pattern probably representing fibres of different types and origin. Thus, CCK-LI coexists with dopamine in two anatomically and morphologically distinguishable systems, one located in the periventricular area, increasing in size in the caudal direction to occupy most of the cauda, and a second system consisting of very fine dots in the medial half of the caudate nucleus. These two fibre types disappeared after 6-OH-DA treatment. A third system consisted of strongly fluorescent patches distributed at all levels of the caudate nucleus, mainly in its medial half. A diffuse, weakly fluorescent network of CCK-positive fibres was also found over the entire caudate nucleus. The latter two systems did not disappear after 6-OH-DA. Finally, local CCK-positive cell bodies were seen in small numbers, mainly in the ventral aspects of the caudate nucleus.(ABSTRACT TRUNCATED AT 400 WORDS)